Randomized phase III study to evaluate the impact of secondary cytoreductive surgery in recurrent ovarian cancer: Final analysis of AGO DESKTOP III/ENGOT-ov20 - Bois, AD; Cescon, DW; Rugo, HS (J Clin Oncol, 2020)